EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

OC08 | HEADACHE OUTCOME AFTER MIDDLE-MENINGEAL ARTERY EMBOLIZATION IN SUBDURAL HEMATOMA

Confinia Cephalalgica · 03.11.2026 · 36 (s1)

DOI: 10.4081/cc.2026.15946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Confinia Cephalalgica, online erschienen am 03.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Middle meningeal artery embolization (MMAE) has recently emerged as a promising adjunctive or alternative therapeutic strategy for chronic subdural hematoma (cSDH). Yet, beyond its role in cSDH, the MMA is also implicated in headache pathophysiology. Although MMA vasodilation alone does not fully explain migraine pain, modulation of dural vascular signaling may play a role in the pathogenesis of migraine.

Methods

We conducted a retrospective study including patients who underwent MMAE procedure pre- or post- surgical treatment for cSDH between December 2024 and February 2026.

Results

After applying the inclusion and exclusion criteria, a total of 24 patients (16.55%) out of 145 who underwent MMA embolization procedure for cSDH were included. Among these, 10/24 patients (41.7%) reported headache prior to treatment, whereas 14/24 (58.3%) were headache-free pre-procedure. Among patients with pre-existing headache, 5/10 (50.0%) had migraine and 4/10 (40.0%) had tension-type headache, while one patient presented with headache secondary to the cSDH; 2/5 patients with migraine exhibited a marked improvement of their primary headache disorder after the procedure (these cases were described in detail) and 1/4 with tension-type headache.

Conclusions

Although MMA embolization cannot be considered a treatment for primary headache disorders, the improvement observed in some patients with migraine or tension-type headache in our series may reflect modulation of shared meningeal mechanisms. Prospective studies will be necessary to clarify whether MMA embolization may influence meningeal nociceptive pathways beyond its established role in preventing hematoma recurrence and could be considered as an option for refractory migraine.

Zitieren

APA

(2026). OC08 | HEADACHE OUTCOME AFTER MIDDLE-MENINGEAL ARTERY EMBOLIZATION IN SUBDURAL HEMATOMA. Confinia Cephalalgica, 36(s1). https://doi.org/10.4081/cc.2026.15946

Vancouver

OC08 | HEADACHE OUTCOME AFTER MIDDLE-MENINGEAL ARTERY EMBOLIZATION IN SUBDURAL HEMATOMA. Confinia Cephalalgica. 2026;36(s1). doi:10.4081/cc.2026.15946

BibTeX
@article{euvimed2026,
  title = {OC08 | HEADACHE OUTCOME AFTER MIDDLE-MENINGEAL ARTERY EMBOLIZATION IN SUBDURAL HEMATOMA},
  journal = {Confinia Cephalalgica},
  year = {2026},
  volume = {36},
  number = {s1},
  doi = {10.4081/cc.2026.15946}
}
Kostenlos starten →